IHS Chemical Week
FINE CHEMICALS/BIOTECH

Johnson & Johnson to acquire Alios BioPharma for $1.75 billion

12:01 AM MDT | October 1, 2014 | Natasha Alperowicz

Johnson & Johnson, the biggest maker of consumer health products, has announced a definitive agreement to acquire Alios BioPharma (South San Francisco, CA), a privately held clinical stage biopharmaceutical company focused on developing therapies for...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

API manufacturer Shasun announces merger with Strides Arcolab

Pharmaceutical companies Strides Arcolab (Bangalore, India) and Shasun Pharmaceuticals (Chennai, India) have announced their plans to merge. The boards of directors of the two companies have approved the merger plan. The combination will create a vertically...

Consort Medical to acquire Aesica for $372 million

Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) to health-care firm Consort Medical (Hemel Hempstead, UK) for £230 million ($372 million). Aesica...

Pharma/fine chemicals roundup—30 September 2014

Consort Medical to acquire Aesica for $372 million Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) to health care firm Consort Medical (Hemel Hempstead...

Syngenta appoints new chief operating officer

Syngenta today announced that John Atkin, COO, will retire from the company at the end of 2014. He will be succeeded by Jon Parr, who will assume responsibility for two of the company’s four regions: Europe, Africa and the Mideast (EMAE) and Latin...

Pharma/fine chemicals roundup—23 September 2014

Merck KGaA to acquire Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) says it has entered into a definitive agreement to acquire Sigma-Aldrich (St. Louis) for $17 billion. Merck will acquire all of the outstanding shares of Sigma-Aldrich for...

Synalloy signs toll manufacturing deal

Synalloy Corporation (Spartanburg, SC) announced today that its wholly owned subsidiary, CRI Tolling, LLC, has entered into a three-year tolling agreement to produce biobased polyols for Biobased Technologies (Springdale, AZ). Polyols are the building blocks...

Merck KGaA steps up investment in biosimilar activities

Merck KGaA (Darmstadt, Germany) says its biopharmaceutical division is well on track with implementing the group’s Fit for 2018 transformation and growth program. At an analysts' and investor day at Darmstadt on Friday at its Merck Serono biopharma...

Bayer CropScience forecasts significant growth in agchems markets, confirms capex plans

Bayer CropScience (BCS), the world’s second largest agricultural chemicals producer, at its annual press briefing in Monheim, Germany today said that it is optimistic about future development of the agchems markets and it will continue to invest...

Lupin to manufacture Merck Serono drugs under $1.5-billion deal?

Merck KGaA today declined to comment on a report in The Economic Times of India that it is close to signing a deal, worth $1.5 billion, with India’s pharma major Lupin (Mumbai). The report, citing sources close to the deal, says Lupin is in advanced...

Fine Chemicals/Biotech Archives »











 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa